November 16, 2011
Sorry this post was late. I had to deal with the magazine deadline and a headache-inducing exam. The good news is that this news about BioAmber's IPO filing came in just in time for my editor-in-chief to include it in his upcoming article covering the financing environment within the renewable chemicals space. This article is going to be published on ICIS Chemical Business' November 21 Green Chemicals issue.
So let's analyze some of the S-1 information that BioAmber registered on the US Securities and Exchange Commission (SEC). First of all, BioAmber hopes to raise $150m from this stock offering. We've covered enough of BioAmber and succinic acid developments on the blog that I will enumerate some of the "new information" that stood out in my view: